Clinical Manual of Geriatric Psychopharmacology
Nonfiction, Health & Well Being, Psychology, Psychiatry, Medical, Specialties
| Author: | Sandra A. Jacobson, MD | ISBN: | 9781585625338 |
| Publisher: | American Psychiatric Publishing | Publication: | February 12, 2014 |
| Imprint: | American Psychiatric Association Publishing | Language: | English |
| Author: | Sandra A. Jacobson, MD |
| ISBN: | 9781585625338 |
| Publisher: | American Psychiatric Publishing |
| Publication: | February 12, 2014 |
| Imprint: | American Psychiatric Association Publishing |
| Language: | English |
In the 7 years since the first edition of Clinical Manual of Geriatric Psychopharmacology was published, dozens of new drugs have been released, and older medications have been marketed in different formulations. In addition, research on pharmacokinetics, pharmacodynamics and mechanism of action, potential interactions, and other critical topics has proceeded apace, rendering much of the information in existing guides obsolete. This new volume is both comprehensive and completely up to date, offering information unavailable elsewhere.
New drugs covered include asenapine, paliperidone, iloperidone, lurasidone, desvenlafaxine, vilazodone, long-acting trazodone, milnacipran, armodafinil, extended-release valproate, rotigotine transdermal, tetrabenazine, dextromethorphan, long-acting gabapentin, and transdermal buprenorphine. Each chapter has a standardized format, with topics including pharmacokinetics, pharmacodynamics and mechanism of action, drug interactions, clinical use (which addresses choice of drug, alternative formulations/routes, pre-treatment evaluation, dose and dose titration, PRN use, monitoring treatment, drug levels, managing treatment resistance, switching drugs, duration of treatment, discontinuation, and overdose), adverse effects, and treatment of selected syndromes and disorders. Dozens of tables, boxes, and figures organize and present complex material, such as practice guidelines, in a straightforward manner that is easy to understand and apply, and the concise, bulleted text facilitates reading and comprehension in the clinical setting. "Specific Drug Summaries" -- one-page summaries of prescribing information for individual drugs -- provide fast access to critical information in a simple format.
Designed for residents, fellows, and all clinicians in psychiatry and medicine who diagnose and treat psychiatric and neuropsychiatric conditions affecting geriatric patients, this clinical reference can be used across all treatment settings (inpatient, outpatient, day hospital, consultation, and nursing home). Meticulously referenced and grounded in the latest research, Clinical Manual of Geriatric Psychopharmacology, Second Edition, is the definitive guide to psychotropic use in elderly patients. Clinicians can rely confidently on its up-to-date coverage and authoritative counsel.
In the 7 years since the first edition of Clinical Manual of Geriatric Psychopharmacology was published, dozens of new drugs have been released, and older medications have been marketed in different formulations. In addition, research on pharmacokinetics, pharmacodynamics and mechanism of action, potential interactions, and other critical topics has proceeded apace, rendering much of the information in existing guides obsolete. This new volume is both comprehensive and completely up to date, offering information unavailable elsewhere.
New drugs covered include asenapine, paliperidone, iloperidone, lurasidone, desvenlafaxine, vilazodone, long-acting trazodone, milnacipran, armodafinil, extended-release valproate, rotigotine transdermal, tetrabenazine, dextromethorphan, long-acting gabapentin, and transdermal buprenorphine. Each chapter has a standardized format, with topics including pharmacokinetics, pharmacodynamics and mechanism of action, drug interactions, clinical use (which addresses choice of drug, alternative formulations/routes, pre-treatment evaluation, dose and dose titration, PRN use, monitoring treatment, drug levels, managing treatment resistance, switching drugs, duration of treatment, discontinuation, and overdose), adverse effects, and treatment of selected syndromes and disorders. Dozens of tables, boxes, and figures organize and present complex material, such as practice guidelines, in a straightforward manner that is easy to understand and apply, and the concise, bulleted text facilitates reading and comprehension in the clinical setting. "Specific Drug Summaries" -- one-page summaries of prescribing information for individual drugs -- provide fast access to critical information in a simple format.
Designed for residents, fellows, and all clinicians in psychiatry and medicine who diagnose and treat psychiatric and neuropsychiatric conditions affecting geriatric patients, this clinical reference can be used across all treatment settings (inpatient, outpatient, day hospital, consultation, and nursing home). Meticulously referenced and grounded in the latest research, Clinical Manual of Geriatric Psychopharmacology, Second Edition, is the definitive guide to psychotropic use in elderly patients. Clinicians can rely confidently on its up-to-date coverage and authoritative counsel.
